Pancreatic autoantibodies in inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 10, Issue 6, 2004, Pages 771-777

  Joossens, Sofie ^a   Vermeire, Severine ^a   Van Steen, Kristel ^b   Godefridis, Godelieve ^a   Claessens, Greet ^a   Pierik, Marie ^a   Vlietinck, Robert ^a   Aerts, Raymond ^a   Rutgeerts, Paul ^a   Bossuyt, Xavier ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

Author keywords

Crohn's disease; Inflammatory bowel disease; Pancreatic autoantibodies; Ulcerative colitis

Indexed keywords

ACETYLSALICYLIC ACID; AUTOANTIBODY; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BELGIUM; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELATIVE; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BELGIUM; CASE-CONTROL STUDIES; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; PREVALENCE; SENSITIVITY AND SPECIFICITY;

EID: 9144241207     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200411000-00012     Document Type: Article

References (30)

1. Sartor RB. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am. 1995;24:475-507.
2. Broberger O, Perlmann P. Autoantibodies in human ulcerative colitis. J Exp Med. 1959;110:657-674.
3. Tabaqchali S, O'Donoghue DP, Bettelheim KA. Escherichia coli antibodies in patients with inflammatory bowel disease. Gut 1978;19:108-113.
4. Paganelli R, Pallone F, Montano S, et al. Isotopic analysis of antibody response to food antigen in inflammatory bowel disease. Int Arch Allergy Appl Immunol. 1985;78:81-85.
5. Knoflach P, Park BH, Cunningham R, et al. Serum antibodies to cow's milk proteins in ulcerative colitis and Crohn's disease. Gastroenterology. 1987;92:479-485.
6. Main J, McKenzie H, Yeaman GR, et al. Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. BMJ 1988;297:1105-1106.
7. Rump JA, Scholmerich J, Gross V, et al. A new type of perinuclear antineutrophil cytoplasmic antibody (p-ANCA) in ulcerative colitis but not in Crohn's disease. Immunobiology. 1990;181:406-413.
8. Cohavy O, Bruckner D, Gordon L, et al. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope. Infect Immun. 2000;68: 1542-1548.
9. Sutton C, Kim J, Yamane A, et al. Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology 2000;119: 23-31.
10. Stocker W, Otte M, Ulrich S, et al. Autoimmunity to pancreatic juice in Crohn's disease. Scand J Gastroenterol. 1987;139:41-52.
11. Seibold F, Weber P, Jenss H, et al. Antibodies to trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: specific marker for a subgroup of patients with Crohn's disease. Gut 1991;32:1192-1197.
12. Fricke H, Birkhofer A, Folwaczny C, et al. Characterization of antigens from the human exocrine pancreatic tissue (Pag) relevant as target antigens for autoantibodies in Crohn's disease. Eur J Clin Invest. 1999;29: 41-45.
13. Seibold F, Mork H, Tanza S, et al. Pancreatic autoantibodies in Crohn's disease: a family study. Gut. 1997;40:481-484.
14. Folwaczny C, Noehl N, Endres SP, et al. Antineutrophil and pancreatic autoantibodies in first-degree relatives of patients with inflammatory bowel disease. Scand J Gastroenterol. 1998; 33:523-528.
15. Bottazzo GF, Dean BM, Gorsuch AN, et al. Complement-fixing islet-cell antibodies in type-I diabetes: possible monitors of active beta-cell damage. Lancet. 1980;29:668-672.
16. Bottazzo GF, Gleichmann H. Immunology and Diabetes Workshops: report of the first international workshop on the standardisation of cytoplasmic islet cell antibodies. Diabetologia. 1986;29:125-126.
17. Biotard C, Bonifacio E, Bottazzo GF, et al. Immunology and Diabetes Workshops: report of the third international (Stage 3) workshop on the standardisation of cytoplasmic islet cell antibodies. Diabetologia. 1988; 31:451-452.
18. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;20:1008-1014.
19. National Committee for Clinical Laboratory Standards. Internal quality Control: Principles and Definitions: Approved Guidelines (Vol 11). NCCLS Document C24-A. National Committee for Clinical Laboratory Standards: Wayne, PA; 1991.
20. Vermeire S, Peeters M, Vlietinck R, et al. Anti- Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD and intestinal permeability: a study in familial IBD. Inflamm Bowel Dis. 2001;7:8-15.
21. Hamm RM. Clinical Decision Making Spreadsheet Calculator Available at: http://www.fammed.ouhsc.edu/robhamm. Accessed May 1999.
22. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congress of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000;6:8-15.
23. Farmer R, Michener W, Mortimer E. Studies of familial history among patients with inflammatory bowel disease. Clin Gastroenterol. 1980;9: 271-277.
24. Monsen U, Bernell O, Johansson C, et al. Prevalence of inflammatory bowel disease among relatives of patients with Crohn's disease. Scand J Gastroenterol. 1991;26:302-306.
25. Orholm M, Fonager K, Sorensen H. Risk of ulcerative colitis and Crohn's disease among offsprings of patients with chronic inflammatory bowel disease. Am J Gastroenterol. 1999;94:3236-3238.
26. Vasiliauskas EA, Kam LY, Karp LC, et al. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut. 2000;47:487-496.
27. Quinton JF, Sendid B, Reumaux D, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut. 1998;42:788-791.
28. Vasiliauskas EA, Plevy SE, Landers CJ, et al. Perinuclear anti-neutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup. Gastroenterology 1996;110:1810-1819.
29. Peeters M, Cortot A, Vermeire S, et al. Familial and sporadic inflammatory bowel disease: different entities? Inflamm Bowel Dis. 2000;6:314-320.
30. Halme L, Turunen U, Helio T, et al. Familial and sporadic inflammatory bowel disease: Comparison of clinical features and serologic markers in a genetically homogeneous population. Scand J Gastroenterol. 2002;37: 692-698.